E-LIB Suche - Ergebnisse für: Viziteu, Elena

1

The BLM helicase is a new therapeutic target in multiple my..:

Ovejero, Sara ; Viziteu, Elena ; Dutrieux, Laure...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

2

In Vitro Differentiation Model of Human Normal Memory B Cel..

JoVE : Immunology and Infection

Jourdan, Michel ; de Boussac, Hugues ; Viziteu, Elena.. , 2019

Link: https://www.jove.com/t/5..

3

RECQ helicases are deregulated in hematological malignancie..:

Viziteu, Elena ; Kassambara, Alboukadel ; Pasero, Philippe..
Biomarker Research. 4 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

4

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumou..:

Viziteu, Elena ; Grandmougin, Camille ; Goldschmidt, Hartmut...
British Journal of Cancer. 114 (2016) 5 - p. 519-523 , 2016

Link: https://doi.org/10.1038/..

5

The BLM helicase is a new therapeutic target in multiple my..:

Ovejero, Sara ; Viziteu, Elena ; Dutrieux, Laure...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.983181. , 2022

Link: https://hal.science/hal-..

6

The BLM helicase is a new therapeutic target in multiple my..:

Ovejero, Sara ; Viziteu, Elena ; Dutrieux, Laure...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.983181. , 2022

Link: https://hal.science/hal-..

7

The BLM helicase is a new therapeutic target in multiple my..:

Ovejero, Sara ; Viziteu, Elena ; Dutrieux, Laure...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.983181. , 2022

Link: https://hal.science/hal-..

8

The BLM helicase is a new therapeutic target in multiple my..:

Ovejero, Sara ; Viziteu, Elena ; Dutrieux, Laure...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.983181. , 2022

Link: https://hal.science/hal-..

9

The BLM helicase is a new therapeutic target in multiple my..:

Ovejero, Sara ; Viziteu, Elena ; Dutrieux, Laure...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.983181. , 2022

Link: https://hal.science/hal-..

10

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumou..:

Viziteu, Elena ; Grandmougin, Camille ; Goldschmidt, Harmut...
info:eu-repo/semantics/altIdentifier/doi/10.1038/bjc.2016.20. , 2016

Link: https://hal.science/hal-..

11

RECQ helicases are deregulated in hematological malignancie..:

Viziteu, Elena ; Kassambara, Alboukadel ; Pasero, Philippe..
http://www.biomarkerres.org/content/4/1/3. , 2016

Link: http://www.biomarkerres...

12

RECQ helicases are deregulated in hematological malignancie..:

Viziteu, Elena ; Kassambara, Alboukadel ; Pasero, Philippe..
info:eu-repo/semantics/altIdentifier/doi/10.1186/s40364-016-0057-4. , 2016

Link: https://www.hal.inserm.f..

13

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumou..:

Viziteu, Elena ; Grandmougin, Camille ; Goldschmidt, Hartmut...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782210/. , 2016

Link: http://www.ncbi.nlm.nih...

14

RECQ helicases are deregulated in hematological malignancie..:

Viziteu, Elena ; Kassambara, Alboukadel ; Pasero, Philippe..
info:eu-repo/semantics/altIdentifier/doi/10.1186/s40364-016-0057-4. , 2016

Link: https://www.hal.inserm.f..

15

RECQ helicases are deregulated in hematological malignancie..:

Viziteu, Elena ; Kassambara, Alboukadel ; Pasero, Philippe..
info:eu-repo/semantics/altIdentifier/doi/10.1186/s40364-016-0057-4. , 2016

Link: https://inserm.hal.scien..